Compare EBF & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EBF | CTKB |
|---|---|---|
| Founded | 1909 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 533.9M | 595.2M |
| IPO Year | 1994 | 2021 |
| Metric | EBF | CTKB |
|---|---|---|
| Price | $20.40 | $4.64 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.63 |
| AVG Volume (30 Days) | 145.3K | ★ 521.3K |
| Earning Date | 04-20-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.85% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.31 | N/A |
| Revenue | N/A | ★ $193,015,000.00 |
| Revenue This Year | $2.96 | $5.42 |
| Revenue Next Year | N/A | $7.03 |
| P/E Ratio | $16.12 | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $16.30 | $2.37 |
| 52 Week High | $22.36 | $6.18 |
| Indicator | EBF | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 43.86 | 55.39 |
| Support Level | $19.96 | $4.56 |
| Resistance Level | $21.52 | $4.80 |
| Average True Range (ATR) | 0.57 | 0.19 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 38.67 | 86.72 |
Ennis Inc is a manufacturer and supplier of print products for the wholesale trade. The company's products include advertising specialties, business forms and supplies, commercial printing, eCommerce solutions, envelopes, labels and tags, and folders and packaging. Its products include snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products in short, medium and long runs under the following labels: Ennis, Royal Business Forms, Block Graphics, 360 Custom LabelsSM, ColorWorx, Enfusion, among others.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.